April 25, 2024

Cell-based Assays Market Size To Cross USD 42.32 Bn By 2032

The global cell-based assays market size accounted for US$ 17.83 Bn in 2022 and is projected to reach around USD 42.32 Bn by 2032, growing at a CAGR of 9.03% from 2023 to 2032.

Cell-based Assays Market Size 2023 To 2032

Report Summary

The global cell-based assays market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the cell-based assays market across the globe.

A comprehensive estimate on the cell-based assays market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of cell-based assays during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2982

Cell-based Assays Market Report Scope

Report CoverageDetails
Market Size in 2023USD 19.44 Billion
Market Size by 2032USD 42.32 Billion
Growth Rate from 2023 to 2032CAGR of 9.03%
Largest MarketNorth America
Base Year2022
Forecast Period2023 To 2032
Segments CoveredBy Type, By Products & Services, By Application, By Technology, and By End-use
Regions CoveredNorth America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized cell-based assays market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read: Cancer Monoclonal Antibodies Market Size Analysis 2023 To 2032

Cell-based Assays Market Players

The report includes the profiles of key cell-based assays market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area

  • Danaher Corporation
  • Lonza Group AG
  • Promega Corporation
  • F. Hoffmann-La Roche AG
  • Charles River Laboratories International, Inc.
  • Menarini Silicon Biosystems, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Macrogen Inc
  • DiscoverX Corporation
  • Corning Inc.
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Perkinelmer, Inc.
  • Biognosys
  • Cell Signaling Technology, Inc.
  • Lebermuth, Inc.
  • Eurofins DiscoverX Products
  • AAT Bioquest, Inc.
  • GE Healthcare
  • Beckman Coulter,Inc.

Market Segmentation

By Type

  • Cell Viability Assay
  • Cytotoxicity Assay
  • Cell Death Assay
  • Cell Proliferation Assay
  • Others

By Products & Services

  • Reagents
  • Assay Kits
    • Cell Growth Assays
    • Reporter Gene Assays
    • Cell Death Assays
    • Second Messenger Assays
  • Microplates
  • Probes & Labels
  • Instruments & Software
  • Cell Lines
    • Primary Cell Lines
    • Stem Cell Lines
    • Immortalized Cell Lines

By Application

  • Basic Research
  • Drug Discovery
  • Other Applications

By Technology

  • Automated Handling
  • Flow Cytometry
  • Label-free Detection
  • High-throughput Screening
  • Others

By End-use 

  • Pharmaceutical and Biotechnology Companies
  • Academic & Government Institutes
  • Contract Research Organizations

Regional Segmentation

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Cell-based Assays Market 

5.1. COVID-19 Landscape: Cell-based Assays Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Cell-based Assays Market, By Type

8.1. Cell-based Assays Market, by Type, 2023-2032

8.1.1. Cell Viability Assay

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Cytotoxicity Assay

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Cell Death Assay

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. Cell Proliferation Assay

8.1.4.1. Market Revenue and Forecast (2020-2032)

8.1.5. Others

8.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Cell-based Assays Market, By Products & Services

9.1. Cell-based Assays Market, by Products & Services, 2023-2032

9.1.1. Reagents

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Assay Kits

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Microplates

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Probes & Labels

9.1.4.1. Market Revenue and Forecast (2020-2032)

9.1.5. Instruments & Software

9.1.5.1. Market Revenue and Forecast (2020-2032)

9.1.6. Cell Lines

9.1.6.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Cell-based Assays Market, By Application 

10.1. Cell-based Assays Market, by Application, 2023-2032

10.1.1. Basic Research

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Drug Discovery

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Other Applications

10.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Cell-based Assays Market, By Technology

11.1. Cell-based Assays Market, by Technology, 2023-2032

11.1.1. Automated Handling

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Flow Cytometry

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Label-free Detection

11.1.3.1. Market Revenue and Forecast (2020-2032)

11.1.4. High-throughput Screening

11.1.4.1. Market Revenue and Forecast (2020-2032)

11.1.5. Others

11.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Cell-based Assays Market, By End-use

12.1. Cell-based Assays Market, by End-use, 2023-2032

12.1.1. Pharmaceutical and Biotechnology Companies

12.1.1.1. Market Revenue and Forecast (2020-2032)

12.1.2. Academic & Government Institutes

12.1.2.1. Market Revenue and Forecast (2020-2032)

12.1.3. Contract Research Organizations

12.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 13. Global Cell-based Assays Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Type (2020-2032)

13.1.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.1.3. Market Revenue and Forecast, by Application (2020-2032)

13.1.4. Market Revenue and Forecast, by Technology (2020-2032)

13.1.5. Market Revenue and Forecast, by End-use (2020-2032)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Type (2020-2032)

13.1.6.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.1.6.3. Market Revenue and Forecast, by Application (2020-2032)

13.1.6.4. Market Revenue and Forecast, by Technology (2020-2032)

13.1.6.5. Market Revenue and Forecast, by End-use (2020-2032)

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Type (2020-2032)

13.1.7.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.1.7.3. Market Revenue and Forecast, by Application (2020-2032)

13.1.7.4. Market Revenue and Forecast, by Technology (2020-2032)

13.1.7.5. Market Revenue and Forecast, by End-use (2020-2032)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Type (2020-2032)

13.2.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.2.3. Market Revenue and Forecast, by Application (2020-2032)

13.2.4. Market Revenue and Forecast, by Technology (2020-2032)

13.2.5. Market Revenue and Forecast, by End-use (2020-2032)

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Type (2020-2032)

13.2.6.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.2.6.3. Market Revenue and Forecast, by Application (2020-2032)

13.2.7. Market Revenue and Forecast, by Technology (2020-2032)

13.2.8. Market Revenue and Forecast, by End-use (2020-2032)

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Type (2020-2032)

13.2.9.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.2.9.3. Market Revenue and Forecast, by Application (2020-2032)

13.2.10. Market Revenue and Forecast, by Technology (2020-2032)

13.2.11. Market Revenue and Forecast, by End-use (2020-2032)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Type (2020-2032)

13.2.12.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.2.12.3. Market Revenue and Forecast, by Application (2020-2032)

13.2.12.4. Market Revenue and Forecast, by Technology (2020-2032)

13.2.13. Market Revenue and Forecast, by End-use (2020-2032)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Type (2020-2032)

13.2.14.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.2.14.3. Market Revenue and Forecast, by Application (2020-2032)

13.2.14.4. Market Revenue and Forecast, by Technology (2020-2032)

13.2.15. Market Revenue and Forecast, by End-use (2020-2032)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Type (2020-2032)

13.3.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.3.3. Market Revenue and Forecast, by Application (2020-2032)

13.3.4. Market Revenue and Forecast, by Technology (2020-2032)

13.3.5. Market Revenue and Forecast, by End-use (2020-2032)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Type (2020-2032)

13.3.6.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.3.6.3. Market Revenue and Forecast, by Application (2020-2032)

13.3.6.4. Market Revenue and Forecast, by Technology (2020-2032)

13.3.7. Market Revenue and Forecast, by End-use (2020-2032)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Type (2020-2032)

13.3.8.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.3.8.3. Market Revenue and Forecast, by Application (2020-2032)

13.3.8.4. Market Revenue and Forecast, by Technology (2020-2032)

13.3.9. Market Revenue and Forecast, by End-use (2020-2032)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Type (2020-2032)

13.3.10.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.3.10.3. Market Revenue and Forecast, by Application (2020-2032)

13.3.10.4. Market Revenue and Forecast, by Technology (2020-2032)

13.3.10.5. Market Revenue and Forecast, by End-use (2020-2032)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Type (2020-2032)

13.3.11.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.3.11.3. Market Revenue and Forecast, by Application (2020-2032)

13.3.11.4. Market Revenue and Forecast, by Technology (2020-2032)

13.3.11.5. Market Revenue and Forecast, by End-use (2020-2032)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Type (2020-2032)

13.4.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.4.3. Market Revenue and Forecast, by Application (2020-2032)

13.4.4. Market Revenue and Forecast, by Technology (2020-2032)

13.4.5. Market Revenue and Forecast, by End-use (2020-2032)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Type (2020-2032)

13.4.6.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.4.6.3. Market Revenue and Forecast, by Application (2020-2032)

13.4.6.4. Market Revenue and Forecast, by Technology (2020-2032)

13.4.7. Market Revenue and Forecast, by End-use (2020-2032)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Type (2020-2032)

13.4.8.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.4.8.3. Market Revenue and Forecast, by Application (2020-2032)

13.4.8.4. Market Revenue and Forecast, by Technology (2020-2032)

13.4.9. Market Revenue and Forecast, by End-use (2020-2032)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Type (2020-2032)

13.4.10.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.4.10.3. Market Revenue and Forecast, by Application (2020-2032)

13.4.10.4. Market Revenue and Forecast, by Technology (2020-2032)

13.4.10.5. Market Revenue and Forecast, by End-use (2020-2032)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Type (2020-2032)

13.4.11.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.4.11.3. Market Revenue and Forecast, by Application (2020-2032)

13.4.11.4. Market Revenue and Forecast, by Technology (2020-2032)

13.4.11.5. Market Revenue and Forecast, by End-use (2020-2032)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Type (2020-2032)

13.5.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.5.3. Market Revenue and Forecast, by Application (2020-2032)

13.5.4. Market Revenue and Forecast, by Technology (2020-2032)

13.5.5. Market Revenue and Forecast, by End-use (2020-2032)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Type (2020-2032)

13.5.6.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.5.6.3. Market Revenue and Forecast, by Application (2020-2032)

13.5.6.4. Market Revenue and Forecast, by Technology (2020-2032)

13.5.7. Market Revenue and Forecast, by End-use (2020-2032)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Type (2020-2032)

13.5.8.2. Market Revenue and Forecast, by Products & Services (2020-2032)

13.5.8.3. Market Revenue and Forecast, by Application (2020-2032)

13.5.8.4. Market Revenue and Forecast, by Technology (2020-2032)

13.5.8.5. Market Revenue and Forecast, by End-use (2020-2032)

Chapter 14. Company Profiles

14.1. Danaher Corporation

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Lonza Group AG

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Promega Corporation

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. F. Hoffmann-La Roche AG

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Charles River Laboratories International, Inc.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Menarini Silicon Biosystems, Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Becton, Dickinson and Company

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Bio-Rad Laboratories, Inc.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Macrogen Inc

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. DiscoverX Corporation

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com